The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
The number of reported anti-semitic incidents in the UK have increased by just over 50%, figures released by a charity have suggested.
Athletes competing at next years Summer Olympic Games in Rio de Janeiro will be using waters contaminated with human feces, a study finds.
Former One Direction star Zayn Malik said he will reveal the "real me" to fans after penning a new record deal.